Rosenblum M - Search Results

1

Phase I study of recombinant methionyl human consensus interferon (r-metHuIFN-Con1).

Neidhart JA, Schmidt S, Rosenblum M, Raber MN, Quesada JR, Alton NK, Downing M. Neidhart JA, et al. Among authors: rosenblum m. J Biol Response Mod. 1988 Jun;7(3):240-8. J Biol Response Mod. 1988. PMID: 3392552 Clinical Trial.

2

Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.

Kurzrock R, Rosenblum MG, Quesada JR, Sherwin SA, Itri LM, Gutterman JU. Kurzrock R, et al. Among authors: rosenblum mg. J Clin Oncol. 1986 Nov;4(11):1677-83. doi: 10.1200/JCO.1986.4.11.1677. J Clin Oncol. 1986. PMID: 3095504

3

Phase I study of i.v. administered recombinant gamma interferon in cancer patients.

Kurzrock R, Quesada JR, Rosenblum MG, Sherwin SA, Gutterman JU. Kurzrock R, et al. Among authors: rosenblum mg. Cancer Treat Rep. 1986 Dec;70(12):1357-64. Cancer Treat Rep. 1986. PMID: 3098417 Clinical Trial.

4

Initial clinical studies with copovithane.

Hortobagyi GN, Hersh EM, Papadopoulos NE, Frye D, Rios A, Reuben JM, Plager C, Rosenblum M, Quesada J. Hortobagyi GN, et al. Among authors: rosenblum m. J Biol Response Mod. 1986 Aug;5(4):319-29. J Biol Response Mod. 1986. PMID: 2942646

5

Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.

Kurzrock R, Rosenblum MG, Sherwin SA, Rios A, Talpaz M, Quesada JR, Gutterman JU. Kurzrock R, et al. Among authors: rosenblum mg. Cancer Res. 1985 Jun;45(6):2866-72. Cancer Res. 1985. PMID: 3921249

6

Pharmacokinetic study of partially pure gamma-interferon in cancer patients.

Gutterman JU, Rosenblum MG, Rios A, Fritsche HA, Quesada JR. Gutterman JU, et al. Among authors: rosenblum mg. Cancer Res. 1984 Sep;44(9):4164-71. Cancer Res. 1984. PMID: 6430557

7

Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.

Murray JL, Zukiwski AA, Mujoo K, Rosenblum MG. Murray JL, et al. Among authors: rosenblum mg. J Biol Response Mod. 1990 Dec;9(6):556-63. J Biol Response Mod. 1990. PMID: 2074442

8

Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.

Murray JL, Stuckey SE, Pillow JK, Rosenblum MG, Gutterman JU. Murray JL, et al. Among authors: rosenblum mg. J Biol Response Mod. 1988 Apr;7(2):152-61. J Biol Response Mod. 1988. PMID: 3129542

9

Phase I study of cancer therapy with recombinant interleukin-2 administered by intravenous bolus injection.

Hersh EM, Murray JL, Hong WK, Rosenblum MG, Reuben JM, Weilbaecher R, Sarwal AN, Bradley EC, Konrad M, Arnett FC. Hersh EM, et al. Among authors: rosenblum mg. Biotherapy. 1989;1(3):215-26. doi: 10.1007/BF02170890. Biotherapy. 1989. PMID: 2642025

10

Phase I study of recombinant human interleukin-3 in patients with bone marrow failure.

Kurzrock R, Talpaz M, Estrov Z, Rosenblum MG, Gutterman JU. Kurzrock R, et al. Among authors: rosenblum mg. J Clin Oncol. 1991 Jul;9(7):1241-50. doi: 10.1200/JCO.1991.9.7.1241. J Clin Oncol. 1991. PMID: 2045865 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,063 results

Search Page

Filters